全部成果分类

按条件检索“17”条记录

已选条件: 核心收录: CPCI-S ×
导出
  • 排序
  • 显示
1. Exosomal microRNA: a novel biomarker for breast cancer PubMed CPCI-S SCIE SCOPUS

作者:He, YJ; Deng, F; Yang, SJ; Wang, DD; Chen, X; Zhong, SL; Zhao, JH; Tang, JH

作者机构:[He, Yunjie; Deng, Fei; Yang, Sujin; Tang, Jinhai] Nanjing Med Univ, Clin Sch 1, Nanjing 210029, Jiangsu, Peoples R China.; [Wang, Dandan; Chen, Xiu; 更多

关键词:biomarker; breast cancer; drug resistance; exosomal miRNAs; exosome; exosome isolation; metastasis; microRNA; proliferation; tumor microenvironment

来源:BIOMARKERS IN MEDICINE,2018,Vol.12,Issue.2

Scopus被引频次:2

ESI学科:MOLECULAR BIOLOGY & GENETICS

最新一期影响因子:2.02

资源类型:外文期刊论文;外文会议论文

2. A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab CPCI-S SCIE

作者:Xu, BH; Ma, F; Ouyang, QC; Li, W; Jiang, ZF; Tong, ZS; Liu, YJ; Li, HP; Yu, SY; Feng, JF; Wang, SS; Hu, XC; Zhu, XY; Zou, JJ

作者机构:[Xu, BH; Ma, F; Ouyang, QC; Li, W; Jiang, ZF; Tong, ZS; Liu, YJ; Li, HP; Yu, SY; Feng, JF; Wang, SS; Hu, XC; Zhu, XY; Zou, JJ]Canc Hosp, Peking Union 更多

会议名称:San Antonio Breast Cancer Symposium

会议日期:DEC 05-09, 2017

来源:CANCER RESEARCH,2018,Vol.78,Issue.4

ESI学科:CLINICAL MEDICINE

最新一期影响因子:9.122

资源类型:外文会议论文

4. Hypofractionated Intensity-Modulated Radiation Therapy for Stage III Non-Small-Cell Lung Cancer: A Retrospective Study CPCI-S SCIE

作者:Zhu, X; Kong, C; He, X

作者机构:[Zhu, X.; Kong, C.; He, X.] Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China.

会议名称:60th Annual Meeting of the American-Society-for-Radiation-Oncology; (ASTRO)

会议日期:OCT 21-24, 2018

来源:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,2018,Vol.102,Issue.3

资源类型:外文会议论文

5. Abiraterone acetate (AA) plus prednisone (P) 5 mg QD in metastatic castration-naive prostate cancer (mCNPC): Detailed safety analyses from the LATITUDE phase 3 trial. CPCI-S SCIE

作者:Fizazi, K; Tran, N; Fein, LE; Matsubara, N; Bjartell, A; Galli, L; Lee, JL; Mazhar, D; North, SA; Olmos, D; Suttmann, H; Zou, Q; Li, S; Martin, JL; Park, YC; Sulur, G; Deprince, K; De Porre, P; Chi, KN

作者机构:[Fizazi, K; Tran, N; Fein, LE; Matsubara, N; Bjartell, A; Galli, L; Lee, JL; Mazhar, D; North, SA; Olmos, D; Suttmann, H; Zou, Q; Li, S; Martin, JL; P 更多

会议名称:Genitourinary Cancers Symposium

会议日期:FEB 08-10, 2018

来源:JOURNAL OF CLINICAL ONCOLOGY,2018,Vol.36,Issue.6

资源类型:外文会议论文

6. Evidence-based two-and-seven criteria according to tumor number and size best help to predict survival of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization CPCI-S SCIE

作者:Xia, D; Bai, W; Huang, M; Sun, J; Wang, E; Li, H; Li, J; Zhao, H; Pan, X; Chen, S; Gong, W; Zhu, X; Shao, G; Mu, W; Chen, Z; Wu, J; Liu, J; Li, J; Song, J; Zhang, C; Shi, H; Li, Z; Yang, S; Wang, W; Zheng, Y; Xu, J; Wang, W; Yuan, J; Li, X; Niu, J; Yin, Z; Fan, D; Xia, J; Han, G

作者机构:[Xia, D.; Bai, W.; Wang, E.; Wang, W.; Yuan, J.; Li, X.; Niu, J.; Yin, Z.; Fan, D.; Han, G.] Forth Mil Med Univ, Xijing Hosp Digest Dis, Dept Liver Di 更多

会议名称:International Liver Congress / 52nd Annual Meeting of the; European-Association-for-the-Study-of-the-Liver

会议日期:APR 19-23, 2017

来源:JOURNAL OF HEPATOLOGY,2017,Vol.66,Issue.1

ESI学科:CLINICAL MEDICINE

最新一期影响因子:12.486

资源类型:外文会议论文

8. Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy (CCRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A randomized controlled multi-centered trial CPCI-S

作者:He, X; Yin, H; Guo, W; Sun, X; Hu, X; Yan, P; Li, F; Huang, S; Zhou, H; Zhang, F; Wang, B; Bian, X; Wei, Q; Wu, J; Wang, F; Song, D; Liu, J; Zhou, B

作者机构:[He, X.; Guo, W.; Yan, P.; Li, F.; Huang, S.; Bian, X.; Wei, Q.; Wu, J.; Wang, F.; Song, D.; Liu, J.] Nanjing Med Univ, Dept Radiat Oncol, Affiliated 更多

会议名称:42nd European-Society-for-Medical-Oncology Congress (ESMO)

会议日期:SEP 08-12, 2017

来源:ANNALS OF ONCOLOGY,2017,Vol.28

ESI学科:CLINICAL MEDICINE

最新一期影响因子:11.855

资源类型:外文会议论文

11. A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare). CPCI-S SCIE

作者:Zhu, J; Sun, XC; Zhang, T; Liu, AW; Zhu, Y; Jia, JH; Zhu, YQ; Tan, SS; Zhou, JY; Zhang, C; Wang, X; Cai, G; Luo, B; Wu, JX; Yang, JL; Zhang, Z

作者机构:[Zhu, J; Sun, XC; Zhang, T; Liu, AW; Zhu, Y; Jia, JH; Zhu, YQ; Tan, SS; Zhou, JY; Zhang, C; Wang, X; Cai, G; Luo, B; Wu, JX; Yang, JL; Zhang, Z]Fudan 更多

会议名称:53rd Annual Clinical Science Meeting of the; American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets,; New Drugs - Her2 and MET

会议日期:JUN 02-07, 2017

来源:JOURNAL OF CLINICAL ONCOLOGY,2017,Vol.35

资源类型:外文会议论文

13. Therapeutic p53 gene agent in the treatment of NPC cases: Preliminary results CPCI-S SCIE

作者:He, X; Xu, JH; Guo, WJ; Kong, C

作者机构:[He, X; Xu, JH; Guo, WJ; Kong, C]Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China., Nanjing Med Univ, Jiangsu Canc Hosp, 更多

会议名称:Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

会议日期:MAY 29-JUN 02, 2015

来源:JOURNAL OF CLINICAL ONCOLOGY,2015,Vol.33,Issue.15

ESI学科:CLINICAL MEDICINE

JCR分区:Q1

当年影响因子:20.982

最新一期影响因子:24.008

资源类型:外文会议论文

15. A phase II, multicenter, placebo-controlled trial of apatinib in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after two previous treatment regimens. CPCI-S SCIE

作者:Zhang, L; Shi, MQ; Huang, C; Liu, XQ; Xiong, JP; Chen, GY; Liu, W; Liu, WC; Zhang, YP; Li, K; Yu, H; Jiang, HY

作者机构:[Zhang, L; Shi, MQ; Huang, C; Liu, XQ; Xiong, JP; Chen, GY; Liu, W; Liu, WC; Zhang, YP; Li, K; Yu, H; Jiang, HY]Sun Yat Sen Univ 更多

会议名称:48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

会议日期:JUN 01-06, 2012

来源:JOURNAL OF CLINICAL ONCOLOGY,2012,Vol.30,Issue.15

WOS被引频次:3

ESI学科:CLINICAL MEDICINE

JCR分区:Q1

当年影响因子:18.038

最新一期影响因子:24.008

资源类型:外文会议论文

TOP